Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024
上市后措施中纳入真实世界数据：以2013年至2024年欧盟获批的先进疗法药品为例
期刊:BioDrugs
影响因子:6.9
doi:10.1007/s40259-025-00737-x
Almeida, Diogo; Mandslay, Diana; Mol, Peter G M; Sepodes, Bruno; Torre, Carla
